TEVA insider transactions
Teva Pharmaceutical Industries Limited (TEVA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for TEVA
- EVP, Global Operations Shields Matthew converted options into 16,195 units of Ordinary Shares and sold $532,330 worth of Ordinary Shares (16,195 units at $32.87) as part of a pre-agreed trading plan (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Director Zaks Tal Zvi4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Director Satchi-Fainaro Ronit4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Director Nisen Perry4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Director Lieberman Gerald M4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Director Elstein Amir4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Director Crane Rosemary A4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Director Lichtenstein Chen4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Director Barer Sol J4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Director Mignone Roberto4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Business Development Lippman Evan sold $1,482,367 worth of Ordinary Shares (41,658 units at $35.58) as part of a pre-agreed trading plan and converted options into 85,849 units of Ordinary Shares (SEC Form 4) (for tax liability)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Chief Financial Officer Kalif Eliyahu Sharon sold $5,457,375 worth of Ordinary Shares (153,251 units at $35.61) as part of a pre-agreed trading plan, decreasing direct ownership by 47% to 172,184 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Chief Accounting Officer Weiss Amir sold $384,444 worth of Ordinary Shares (10,679 units at $36.00), decreasing direct ownership by 35% to 20,016 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Europe Commercial Daniell Richard sold $1,062,000 worth of Ordinary Shares (30,000 units at $35.40), decreasing direct ownership by 35% to 55,755 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- See "Remarks" Sabag Mark sold $5,045,118 worth of Ordinary Shares (144,180 units at $34.99), decreasing direct ownership by 64% to 80,760 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, U.S. Commercial Fox Christine sold $750,620 worth of Ordinary Shares (21,258 units at $35.31), decreasing direct ownership by 25% to 63,647 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Sabag Mark4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- See "Remarks" Sabag Mark converted options into 15,723 units of Ordinary Shares, increasing direct ownership by 6% to 287,042 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Chief Financial Officer Kalif Eliyahu Sharon converted options into 19,916 units of Ordinary Shares, increasing direct ownership by 7% to 325,435 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Chief Accounting Officer Weiss Amir converted options into 3,537 units of Ordinary Shares, increasing direct ownership by 13% to 30,695 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- President and CEO Francis Richard D converted options into 42,452 units of Ordinary Shares and sold $634,160 worth of Ordinary Shares (20,025 units at $31.67), increasing direct ownership by 2% to 1,170,639 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, U.S. Commercial Fox Christine converted options into 17,819 units of Ordinary Shares and sold $250,940 worth of Ordinary Shares (7,924 units at $31.67), increasing direct ownership by 13% to 84,905 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- See "Remarks" Hughes Eric A sold $301,895 worth of Ordinary Shares (9,533 units at $31.67) and converted options into 19,654 units of Ordinary Shares, increasing direct ownership by 10% to 107,711 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Europe Commercial Daniell Richard sold $547,705 worth of Ordinary Shares (17,295 units at $31.67) and converted options into 17,295 units of Ordinary Shares (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- See "Remarks" Jover Placid converted options into 14,150 units of Ordinary Shares and sold $448,108 worth of Ordinary Shares (14,150 units at $31.67) (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Interim Chief Legal Officer Savage Brian converted options into 3,580 units of Ordinary Shares and sold $35,690 worth of Ordinary Shares (1,127 units at $31.67), increasing direct ownership by 29% to 10,914 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Global Operations Shields Matthew converted options into 17,295 units of Ordinary Shares and sold $547,705 worth of Ordinary Shares (17,295 units at $31.67) (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- President and CEO Francis Richard D converted options into 50,223 units of Ordinary Shares and sold $759,442 worth of Ordinary Shares (23,393 units at $32.46), increasing direct ownership by 2% to 1,148,212 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Europe Commercial Daniell Richard converted options into 53,973 units of Ordinary Shares and sold $2,983,517 worth of Ordinary Shares (91,345 units at $32.66), decreasing direct ownership by 30% to 85,755 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by See "Remarks" Jover Placid4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by EVP, Global Operations Shields Matthew4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- See "Remarks" Sabag Mark converted options into 52,113 units of Ordinary Shares, increasing direct ownership by 24% to 271,319 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by EVP, Business Development Lippman Evan4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- See "Remarks" Hughes Eric A converted options into 23,251 units of Ordinary Shares and sold $366,102 worth of Ordinary Shares (11,277 units at $32.46), increasing direct ownership by 14% to 97,590 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Chief Financial Officer Kalif Eliyahu Sharon converted options into 56,763 units of Ordinary Shares, increasing direct ownership by 23% to 305,519 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, U.S. Commercial Fox Christine converted options into 20,461 units of Ordinary Shares and sold $295,362 worth of Ordinary Shares (9,098 units at $32.46), increasing direct ownership by 18% to 75,010 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Interim Chief Legal Officer Savage Brian converted options into 8,210 units of Ordinary Shares and sold $86,843 worth of Ordinary Shares (2,675 units at $32.46), increasing direct ownership by 189% to 8,461 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Chief Accounting Officer Weiss Amir converted options into 16,329 units of Ordinary Shares, increasing direct ownership by 151% to 27,158 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Chief Accounting Officer Weiss Amir converted options into 5,179 units of Ordinary Shares, increasing direct ownership by 92% to 10,829 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Europe Commercial Daniell Richard sold $4,173,942 worth of Ordinary Shares (128,985 units at $32.36) and converted options into 203,728 units of Ordinary Shares, increasing direct ownership by 154% to 123,127 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- See "Remarks" Sabag Mark converted options into 166,378 units of Ordinary Shares, increasing direct ownership by 315% to 219,206 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Interim Chief Legal Officer Savage Brian converted options into 3,461 units of Ordinary Shares and sold $41,227 worth of Ordinary Shares (1,274 units at $32.36), increasing direct ownership by 296% to 2,926 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- President and CEO Francis Richard D converted options into 958,546 units of Ordinary Shares and sold $14,333,332 worth of Ordinary Shares (442,935 units at $32.36), increasing direct ownership by 85% to 1,121,382 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Chief Financial Officer Kalif Eliyahu Sharon converted options into 191,278 units of Ordinary Shares, increasing direct ownership by 333% to 248,756 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- See "Remarks" Hughes Eric A converted options into 166,378 units of Ordinary Shares and sold $2,613,450 worth of Ordinary Shares (80,762 units at $32.36) (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Chief Financial Officer Kalif Eliyahu Sharon sold $11,634,708 worth of Ordinary Shares (345,810 units at $33.64), decreasing direct ownership by 86% to 57,478 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- New insider Savage Brian claimed ownership of 739 units of Ordinary Shares (SEC Form 3)3 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- President and CEO Francis Richard D converted options into 781,766 units of Ordinary Shares and sold $15,324,799 worth of Ordinary Shares (447,778 units at $34.22), increasing direct ownership by 123% to 605,771 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by EVP, Chief Financial Officer Kalif Eliyahu Sharon4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by See "Remarks" Hughes Eric A4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by See "Remarks" Sabag Mark4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by Exec. VP, European Commercial Daniell Richard4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- SEC Form 4 filed by President and CEO Francis Richard D4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Chief Accounting Officer Weiss Amir sold $371,504 worth of Ordinary Shares (12,300 units at $30.20), decreasing direct ownership by 69% to 5,650 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Director Mignone Roberto sold $2,340,646 worth of Ordinary Shares (77,400 units at $30.24) (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Exec. VP, European Commercial Daniell Richard exercised 115,468 units of Ordinary Shares at a strike of $18.40 and sold $3,311,126 worth of Ordinary Shares (115,468 units at $28.68) (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- See "Remarks" Sabag Mark sold $6,230,754 worth of Ordinary Shares (216,892 units at $28.73) and exercised 118,724 units of Ordinary Shares at a strike of $18.61, decreasing direct ownership by 65% to 52,828 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Director Lichtenstein Chen converted options into 4,804 units of Ordinary Shares (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- Director Mignone Roberto sold $1,301,505 worth of Ordinary Shares (50,000 units at $26.03) (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)
- EVP, Head of U.S. Commercial Fox Christine converted options into 63,492 units of Ordinary Shares and sold $699,523 worth of Ordinary Shares (28,229 units at $24.78), increasing direct ownership by 124% to 63,647 units (SEC Form 4)4 - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Issuer)